
Conexeu Sciences Closes $5 Million Funding For FDA Push
The Reno biotech firm plans to submit its Ten Minute Tissue device for regulatory review in the first quarter of 2027.
Live Poll
Is now a good time for individual investors to participate in private company stock offerings?

